TABLE 6.
Variable | FN (n = 34) | FLUS (n = 35) | OR | P |
---|---|---|---|---|
Age, range, y | 17–79 | 20–74 | — | — |
Sex, No. | — | — | ||
Female | 30 | 26 | ||
Male | 4 | 9 | ||
Molecular alterations, No. | ||||
RAS alone | 13 | 23 | 0.33 | .02 |
RAS with others | 21 | 12 | ||
Procedure, No. | ||||
Lobectomy | 15 | 22 | 0.47 | .09 |
Total | 19 | 13 | ||
Histology, No. | ||||
Nonneoplastic | 14 | 19 | 0.3 | .025a |
Neoplastic | 6 | 10 | ||
Malignant | 14 | 6 | ||
Molecular alteration and histology correlation, No. | ||||
RAS alone + negative histology | 11 | 19 | 1.15 | .72 |
RAS alone + positive histology | 2 | 4 | ||
RAS and others + negative histology | 9 | 10 | 0.159 | .03 |
RAS and others + positive histology | 12 | 2 | ||
Risk of malignancy, % | ||||
RAS alone | 15 | 17 | 0.27 | .003 |
RAS with others | 57 | 17 | ||
RAS (overall) | 38 | 17 |
Abbreviations: FLUS, follicular lesion of undetermined significance; FN, follicular neoplasm; OR, odds ratio.
Nonneoplastic + neoplastic versus malignant = P value.